Description
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs. OTC drugs are sold to consumers by convenience and grocery stores. However, new technology has allowed a new range of outlets including online sales and catalog. Drugs included in OTC segments are pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product.
For the purpose of this study, Kalorama Information has divided products into five general segments:
- Analgesics
- Allergy, Cough, Cold, Flu Remedies
- Gastrointestinal Remedies
- Dermatologics
- Others, including:
- Smoking cessation products
- Sleepaids
- Hair growth remedies
- Diet aids
Revenues for each segment were generated using dollar and unit sales for key products in each segment and region. The report provides examples of OTC drugs in each general region, segmented as follows:
- Asia Pacific and Africa
- Europe
- North America
- South America
The report includes incidence of conditions which are often treated with OTC medicines, health statistics related to the industry, birth rates, world population, populations by region and issues affecting the market as a whole. Information is presented as a worldwide overview, with special emphasis on the U.S., Japan, Germany, and other key markets. The market segments provide an overview of demographics, overview of products available in each region, market estimates and forecasts. Additionally, a competitive analysis of leading providers and profiles of providers is covered.
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2011. Historical data was provided for the years 2007 through 2010, with forecast data provided for 2012 through 2015. Compound annual growth rates (CAGRs) are provided for the 2007-2011 and 2011-2015 periods for each region and/or segment covered. Competitive analysis is provided for the year 2011 with some reference for 2009 and 2010. The forecasted market analysis for 2011-2015 was largely based on demographic trends, new developments, and global expansion.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Background
- Scope and Methodology
- Size and Growth of the Market
- Key Issues and Trends Affecting Market
- Leading Competitors
CHAPTER TWO: INTRODUCTION
- Background
- Distribution and Safety Issues in the United States
- Consumer Advertising/Promotion
- World Health and Life Expectancy
- Life Expectancy
- Birth Rates
- Tobacco Use
- Obesity
- Declining Growth of the World Population
- Prescription vs. Over-the-Counter Industry
- Rx-to-OTC Switch Industry
- Rx-to-OTC Switch Forecast in the United States
- Economic Trends
- Purchasing Power Trends
- U.S. Healthcare Market
- U.S. Healthcare Challenges
- Health Insurance Issues and Trends
- Healthcare Flexible Spending Accounts and OTC Medicines
- Consumer Issues and Trends
- U.S Consumers
- Consumers Around the World
- Access to Professional Medical Services and the Link to Self-Medication
- Online Resources for Health Information
- Regulatory Environment
- Revisions to Pharmaceutical Affairs Law (PAL) in Japan
- Russian Beneficiary Drug Provision Program
- A Third Class of Drugs in the United States
CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
- Overview
- Demographics
- OTC Product Segments
- Market Analysis
- OTC Product Segment Market Analysis
- Markets by Country
CHAPTER FOUR: OTC MARKETS IN EUROPE
- Overview
- Demographics
- OTC Product Segments
- Market Analysis
- OTC Product Segment Market Analysis
- Markets by Country
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
- Overview
- Demographics
- OTC Product Segments
- Market Analysis
- OTC Product Segment Market Analysis
- Markets by Country
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
- Overview
- Demographics
- OTC Product Segments
- Market Analysis
- OTC Product Segment Market Analysis
- Markets by Country
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
- Overview
- OTC Product Segment Market Analysis
- Markets by Country
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
- Overview
- Competitor Analysis
- Significant Agreements, Mergers and Acquisitions
- Procter & Gamble and Teva Pharmaceutical Industries
- Sanofi and Chattem Consumer
- Schering-Plough and Merck & Co.
- Wyeth and Pfizer
- Reckitt Benckiser and Adams Respiratory Therapeutics
- Bristol-Myers Squibb and Novartis AG
- Johnson & Johnson and Pfizer
- Reckitt Benckiser and Boots Healthcare
- Bayer and Roche
- Leading Corporate Profiles
- Bayer Healthcare Ag
- Boehringer Ingelheim Gmbh
- Glaxosmithkline
- Mc Neil Consumer
- (A Johnson & Johnson Company)
- Merck
- Novartis Consumer
- Pfizer
- Procter & Gamble
- Reckitt Benckiser
- Sanofi
- Taisho Pharmaceutical
APPENDIX: LIST OF MAJOR COMPANIES
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1 5: Total World OTC Market Analysis, 2007-2015
- Figure 1-1 : Total World OTC Market Analysis: 2007-2015
CHAPTER TWO: INTRODUCTION
- Table 2-1 : Average Life Expectancy in Years by Country 1980, 2004 and 2011
- Figure 2-1 : Average Life Expectancy in Years by Country 1980 and 2011
- Table 2-2 : Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2012 and 2020
- Table 2-3 : Percent of Smokers by Country
- Figure 2-2 : Average Percent of Smokers Worldwide in Developed Regions
- Table 2-4 : Percent of Obese* Population, 2008
- Table 2-5 : World Population 1980 to 2050
- Figure 2-3 : World Population 1980 to 2050
- Table 2-6 : Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2011
- Figure 2-4 : Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2011
- Table 2-7 : Leading FDA Approved Rx-to-OTC Switches, 1994-2011
- Figure 2-5 : Number of New Rx-to-OTC Switches in the United States, per Year 1976-2011
- Table 2-8
- Table 2-9 : Potential Rx-to-OTC Switches, 2012-2015
- Table 2-9 : P otential Rx-to-OTC Switches, 2012-2015
- Table 2-10 : Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2009
- Figure 2-6 : Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, and 2006
- Table 2-11 : Gross National Income Comparison by Country 2000-2010
- Figure 2-7 : Gross National Income Growth by Country 2000-2010
- Table 2-12 : National Healthcare Expenditures in the United States 1960-2015
- Figure 2-8 : Healthcare Spending as a Percent of GDP in the United States
- Table 2-13 : Health Insurance Trends in the United States 2005-2009
- Table 2-14 : Practicing Physicians per 1,000 Population by Country, 2000-2008
- Figure 2-9 : Internet Users per 100 Inhabitants, 2010
- Figure 2-10 : Typical Pharmacist-Consumer OTC Drug Counseling Session
CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
- Table 3-1 : Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005-2025
- Figure 3-1 : Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005, 2015, and 2025
- Table 3-2 : Total Midyear Population in Africa by Region, 1995-2025
- Figure 3-2 : Total Midyear Population for Africa by Region, 2005, 2015, and 2025
- Table 3-3 : Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer)
- Table 3-4 : Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007, 2011 and 2015
- Figure 3-3 : Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2011
- Figure 3-4 : Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2015
- Table 3-5 : Asia-Pacific/Africa OTC Market Analysis, 2007-2015
- Figure 3-5 : Asia-Pacific/Africa OTC Market Analysis: 2007-2015
- Table 3-6 : Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2007-2015
- Figure 3-6 : Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2007-2015
- Figure 3-7 : Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2011
- Table 3-7 : Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2011
- Figure 3-8 : Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2011
CHAPTER FOUR: OTC MARKETS IN EUROPE
- Table 4-1 : Total Midyear Population by the Five Most Populated Countries in Europe, 2005-2025
- Figure 4-1 : Total Midyear Population by the Five Most Populated Countries in Europe, 2005, 2015, and 2025
- Table 4-2 : Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer)
- Table 4-3 : European OTC Market as a Percentage of World Market, 2007, 2011 and 2015
- Figure 4-2 : European OTC Market as a Percentage of World Market, 2011
- Figure 4-3 : European OTC Market as a Percentage of World Market, 2015
- Table 4-4 : European OTC Market Analysis, 2007-2015
- Figure 4-4 : European OTC Market Analysis: 2007-2015
- Table 4-5 : European OTC Market Analysis, Markets by Product Segment, 2007-2015
- Figure 4-5 : European OTC Market Analysis, Markets by Product Segment, 2007-2015
- Figure 4-6 : European OTC Market Analysis by Product Segment, 2011
- Table 4-6 : European OTC Market Analysis by Selected Country, 2011
- Figure 4-7 : European OTC Market Analysis by Selected Country, 2011
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
- Table 5-1 : Total Midyear Population by the Five Most Populated Countries in North America, 2005-2025
- Figure 5-1 : Total Midyear Population by the Five Most Populated Countries in North America, 2005, 2015, and 2025
- Table 5-2 : Examples of Marketed OTC Products in North America (Product Name by Type and Marketer)
- Table 5-3 : North American OTC Market as a Percentage of World Market, 2007, 2011 and 2015
- Figure 5-2 : North American OTC Market as a Percentage of World Market, 2011
- Figure 5-3 : North American OTC Market as a Percentage of World Market, 2015
- Table 5-4 : North American OTC Market Analysis, 2007-2015
- Figure 5-4 : North American OTC Market Analysis: 2007-2015
- Table 5-5 : North American OTC Market Analysis by Product Segment, 2007-2015
- Figure 5-5 : North American OTC Market Analysis by Product Segment, 2007-2015
- Figure 5-6 : North American OTC Market Analysis by Product Segment, 2011
- Table 5-6 : North American OTC Market Analysis by Selected Country, 2011
- Figure 5-7 : North American OTC Market Analysis by Selected Country, 2011
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
- Table 6-1 : Total Midyear Population by the Five Most Populated Countries in South America, 2005-2025
- Figure 6-1 : Total Midyear Population by the Five Most Populated Countries in South America, 2005, 2015, and 2025
- Table 6-2 : Examples of Marketed OTC Products in South America (Product Name by Type and Marketer)
- Table 6-3 : South American OTC Market as a Percentage of World Market, 2007, 2011 and 2015
- Figure 6-2 : South American OTC Market as a Percentage of World Market, 2011
- Figure 6-3 : South American OTC Market as a Percentage of World Market, 2015
- Table 6-4 : South American OTC Market Analysis, 2007-2015
- Figure 6-4 : South American OTC Market Analysis: 2007-2015
- Table 6-5 : South American OTC Market Analysis by Product Segment, 2007-2015
- Figure 6-5 : South American OTC Market Analysis by Product Segment, 2007-2015
- Figure 6-6 : South American OTC Market Analysis by Product Segment, 2011
- Table 6-6 : South American OTC Market Analysis by Selected Country, 2011
- Figure 6-7 South American OTC Market Analysis by Selected Country, 2011
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
- Table 7-1 : Total World OTC Market Analysis, 2007-2015
- Figure 7-1 : Total World OTC Market Analysis: 2007-2015
- Table 7-2 : Total World OTC Market Analysis, Markets by Product Segment, 2007-2015
- Figure 7-2 : Total World OTC Market Analysis, Markets by Product Segment, 2007-2015
- Figure 7-3 : Total World OTC Market Analysis by Product Segment, 2011
- Figure 7-4 : Total World OTC Market Analysis by Product Segment, 2015
- Table 7-3 : Top Ten World OTC Markets by Country, 2011
- Figure 7-5 : Top Ten World OTC Markets by Country, 2011
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
- Table 8-1 : Leading Suppliers Shares of the OTC Market by Estimated Revenues—2009, 2010 and 2011
- Figure 8-1 : Leading Suppliers Shares of the OTC Market, 2009
- Figure 8-2 : Leading Suppliers Shares of the OTC Market, 2010
- Figure 8-3 : Leading Suppliers Shares of the OTC Market, 2011
